Contrast induced nephropathy natural history, complications and prognosis: Difference between revisions
No edit summary |
Rim Halaby (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Natural history, Complications and Prognosis== | ==Natural history, Complications and Prognosis== | ||
Studies have substantiated greater all-cause and cardiovascular mortality<ref name="pmid15519007">{{cite journal| author=Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I et al.| title=Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. | journal=J Am Coll Cardiol | year= 2004 | volume= 44 | issue= 9 | pages= 1780-5 | pmid=15519007 | doi=10.1016/j.jacc.2004.07.043 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15519007 }} </ref>, prolonged duration of hospitalization<ref name="pmid14668704">{{cite journal| author=McCullough PA, Sandberg KR| title=Epidemiology of contrast-induced nephropathy. | journal=Rev Cardiovasc Med | year= 2003 | volume= 4 Suppl 5 | issue= | pages= S3-9 | pmid=14668704 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14668704 }} </ref>, and late cardiovascular events<ref name="pmid16949375">{{cite journal| author=McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F et al.| title=Epidemiology and prognostic implications of contrast-induced nephropathy. | journal=Am J Cardiol | year= 2006 | volume= 98 | issue= 6A | pages= 5K-13K | pmid=16949375 | doi=10.1016/j.amjcard.2006.01.019 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16949375 }} </ref> associated with CIN. The evidence is seen mostly in patients undergoing PCI. | |||
==References== | ==References== | ||
Revision as of 21:17, 1 October 2013
|
Contrast Induced Nephropathy Microchapters |
|
Differentiating Contrast induced nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Contrast induced nephropathy natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Contrast induced nephropathy natural history, complications and prognosis |
|
FDA on Contrast induced nephropathy natural history, complications and prognosis |
|
CDC on Contrast induced nephropathy natural history, complications and prognosis |
|
Contrast induced nephropathy natural history, complications and prognosis in the news |
|
Blogs on Contrast induced nephropathy natural history, complications and prognosis |
|
Directions to Hospitals Treating Contrast induced nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
The reported incidence varies widely according to the presence or absence of risk factors, and usually associated with a significantly higher risk of in-hospital and 1-year mortality, even in patients who do not need dialysis.
Natural history, Complications and Prognosis
Studies have substantiated greater all-cause and cardiovascular mortality[1], prolonged duration of hospitalization[2], and late cardiovascular events[3] associated with CIN. The evidence is seen mostly in patients undergoing PCI.
References
- ↑ Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I; et al. (2004). "Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction". J Am Coll Cardiol. 44 (9): 1780–5. doi:10.1016/j.jacc.2004.07.043. PMID 15519007.
- ↑ McCullough PA, Sandberg KR (2003). "Epidemiology of contrast-induced nephropathy". Rev Cardiovasc Med. 4 Suppl 5: S3–9. PMID 14668704.
- ↑ McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F; et al. (2006). "Epidemiology and prognostic implications of contrast-induced nephropathy". Am J Cardiol. 98 (6A): 5K–13K. doi:10.1016/j.amjcard.2006.01.019. PMID 16949375.